LysoPE(0:0/20:3(5Z,8Z,11Z))
|
Basic information |
| Metabolite name | LysoPE(0:0/20:3(5Z,8Z,11Z)) |
 | HMDB0011485 |
 |
N/A |
 |
53480934 |
| Synonyms | NA |
| No. of studies | 3 |
|
Basic information |
| Metabolite name | LysoPE(0:0/20:3(5Z,8Z,11Z)) |
| HMDB0011485 |
|
N/A |
|
53480934 |
| Synonyms | NA |
| No. of studies | 3 |
|
Relationship between LysoPE(0:0/20:3(5Z,8Z,11Z)) and depression (count: 3) |
| Study | Study Type  |
Comparison groups | Tissue | Organism | Up/Down regulated |
| Study M460 | Type1 | depressed group vs. control group | Liver | Kunming mouse | Down |
| Study M632 | Type1 | CUMS group vs. control group | Serum | Sprague-Dawley rat | Unknown |
| Study M830 | Type1 | corticosterone group vs. control group | Brain | Swiss mouse | Down |
| Study M830 | Type2 | corticosterone + acupoint catgut embedding group vs. corticosterone group | Brain | Swiss mouse | Up |